|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
134,770,000 |
Market
Cap: |
19.02(B) |
Last
Volume: |
634,333 |
Avg
Vol: |
1,171,182 |
52
Week Range: |
$120.62 - $144.92 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 724 |
Guru Rank Value : 1.3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
1,760 |
18,097 |
18,097 |
100,860 |
Total Sell Value |
$246,400 |
$2,309,019 |
$2,309,019 |
$14,306,288 |
Total People Sold |
1 |
4 |
4 |
6 |
Total Sell Transactions |
1 |
7 |
7 |
21 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Prevoznik Michael E |
SVP & General Counsel |
|
2022-05-17 |
4 |
OE |
$66.51 |
$3,365,672 |
D/D |
50,604 |
89,828 |
|
- |
|
Gregg Vicky B |
Director |
|
2022-04-18 |
4 |
A |
$134.88 |
$8,228 |
D/D |
61 |
15,630 |
|
- |
|
Doherty Catherine T. |
SVP, Group Exec. Clin. Fran. |
|
2022-03-08 |
4 |
AS |
$135.21 |
$950,797 |
D/D |
(7,032) |
67,733 |
|
-0% |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2022-03-08 |
4 |
AS |
$135.21 |
$842,088 |
D/D |
(6,228) |
39,224 |
|
-0% |
|
Deppe Michael J |
VP, Corp. Controller & CAO |
|
2022-03-07 |
4 |
D |
$130.09 |
$118,902 |
D/D |
(914) |
32,011 |
|
- |
|
Deppe Michael J |
VP, Corp. Controller & CAO |
|
2022-03-07 |
4 |
A |
$130.09 |
$327,306 |
D/D |
2,516 |
32,089 |
|
- |
|
Doherty Catherine T. |
SVP, Group Exec. Clin. Fran. |
|
2022-03-07 |
4 |
D |
$130.09 |
$827,372 |
D/D |
(6,360) |
74,765 |
|
- |
|
Doherty Catherine T. |
SVP, Group Exec. Clin. Fran. |
|
2022-03-07 |
4 |
A |
$130.09 |
$1,742,165 |
D/D |
13,392 |
81,125 |
|
- |
|
Guinan Mark |
Executive Vice President & CFO |
|
2022-03-07 |
4 |
D |
$130.09 |
$1,362,693 |
D/D |
(10,475) |
98,981 |
|
- |
|
Guinan Mark |
Executive Vice President & CFO |
|
2022-03-07 |
4 |
A |
$130.09 |
$2,703,270 |
D/D |
20,780 |
109,456 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2022-03-07 |
4 |
D |
$130.09 |
$691,558 |
D/D |
(5,316) |
45,452 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2022-03-07 |
4 |
A |
$130.09 |
$1,501,759 |
D/D |
11,544 |
50,768 |
|
- |
|
Rusckowski Stephen H |
Chairman, CEO and President |
|
2022-03-07 |
4 |
D |
$130.09 |
$4,237,031 |
D/D |
(32,570) |
334,833 |
|
- |
|
Rusckowski Stephen H |
Chairman, CEO and President |
|
2022-03-07 |
4 |
A |
$130.09 |
$9,130,237 |
D/D |
70,184 |
367,403 |
|
- |
|
Davis J. E. |
EVP-Gen. Diagnostics/CEO Elect |
|
2022-03-07 |
4 |
D |
$130.09 |
$1,343,830 |
D/D |
(10,330) |
66,808 |
|
- |
|
Davis J. E. |
EVP-Gen. Diagnostics/CEO Elect |
|
2022-03-07 |
4 |
A |
$130.09 |
$2,583,067 |
D/D |
19,856 |
77,138 |
|
- |
|
Eglinton Manner Carrie |
SVP, Advanced Diagnostics |
|
2022-03-07 |
4 |
D |
$130.09 |
$1,033,825 |
D/D |
(7,947) |
48,391 |
|
- |
|
Eglinton Manner Carrie |
SVP, Advanced Diagnostics |
|
2022-03-07 |
4 |
A |
$130.09 |
$2,102,515 |
D/D |
16,162 |
56,338 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2022-02-28 |
4 |
S |
$130.00 |
$85,930 |
D/D |
(661) |
39,224 |
|
-3% |
|
Eglinton Manner Carrie |
SVP, Advanced Diagnostics |
|
2022-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
11,745 |
40,176 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2022-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
2,741 |
39,885 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2022-02-24 |
4 |
AS |
$126.26 |
$210,728 |
D/D |
(1,669) |
37,144 |
|
5% |
|
Rusckowski Stephen H |
Chairman, CEO and President |
|
2022-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
22,510 |
297,219 |
|
- |
|
Deppe Michael J |
VP, Corp. Controller & CAO |
|
2022-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,681 |
30,408 |
|
- |
|
Doherty Catherine T. |
SVP, Group Exec. Clin. Fran. |
|
2022-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,328 |
67,733 |
|
- |
|
1541 Records found
|
|
Page 8 of 62 |
|
|